Trial Profile
Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Bladder Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 05 Mar 2013 New trial record